Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 9/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.59 |
| ▸ | HTR1A | P08908 | 7/20 | 0.59 |
| ▸ | LMNA | P02545 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | DRD2 | P14416 | 6/20 | 0.59 |
| ▸ | HRH1 | P35367 | 6/20 | 0.59 |
| ▸ | HTR2A | P28223 | 5/20 | 0.59 |
| ▸ | HTR6 | P50406 | 5/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.59 |
| ▸ | DRD1 | P21728 | 5/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.59 |
| ▸ | DRD3 | P35462 | 5/20 | 0.59 |
| ▸ | MTOR | P42345 | 5/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimetacrine SCHEMBL50120 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| SCHEMBL11640552 | 0.88 | CYP2D6 (0.78) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| Dimetacrine SCHEMBL3501515 | 0.87 | CYP2D6 (0.75) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| Dimetacrine SCHEMBL3501514 | 0.87 | CYP2D6 (0.75) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| SCHEMBL13231573 | 0.82 | KMT2A (0.68) | CYP2D6CYP1A2KMT2ALMNAMAPT | |
| Dimetacrine SCHEMBL28221926 | 0.82 | HRH1 (0.71) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| SCHEMBL17739604 | 0.81 | KMT2A (0.68) | CYP2D6CYP1A2KMT2ALMNAMAPT | |
| SCHEMBL12265301 | 0.79 | CYP2D6 (0.66) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| SCHEMBL29025681 | 0.78 | CYP2D6 (0.64) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A | |
| SCHEMBL11640659 | 0.78 | KMT2A (0.63) | CYP2D6CYP1A2KMT2ASLC6A4HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119587525-A | Dimethocaine composite preparation and preparation method thereof | 海南三帝制药有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-3706762-B1 | N4-HYDROXYCYTIDINE DERIVATIVE AND ANTI-VIRAL USES RELATED THERETO | UNIV EMORY (US) | 2024-10-16 | — | — | EP | claimed |
| CN-118541143-A | Gastric retentive oral dosage unit containing local anesthetic | 欧莱克萨有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-117651571-A | Powder preparation for tissue repair, preparation method thereof and injection composition for tissue repair comprising powder preparation | 三养控股公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117425498-A | Novel peptide conjugates | 艾缇亚(上海)制药有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-116615261-A | Crosslinked hyaluronic acid hydrogel crosslinked using crosslinking agent and polyol and filler comprising same | 株式会社LG化学 | 2023-08-18 | — | — | CN | claimed |
| EP-4577246-A1 | DENDRIMER CONJUGATES OF ANTIDEPRESSANT AND ANTIPSYCHOTIC AGENTS AND THEIR METHODS OF USE | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| CN-120129541-A | Powder formulation for tissue repair and injection composition for tissue repair comprising the same | 三养控股公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-119587525-A | Dimethocaine composite preparation and preparation method thereof | 海南三帝制药有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-113227131-B | Modified antibody Fc and methods of use thereof | 豪夫迈·罗氏有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-113413393-B | Multi-unit drug delivery device and method | 塔里斯生物医药公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024044760-A9 | DENDRIMER CONJUGATES OF ANTIDEPRESSANT AND ANTIPSYCHOTIC AGENTS AND THEIR METHODS OF USE | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-12-26 | — | — | WO | disclosed |
| CN-116615261-A | Crosslinked hyaluronic acid hydrogel crosslinked using crosslinking agent and polyol and filler comprising same | 株式会社LG化学 | 2023-08-18 | — | — | CN | disclosed |
| CN-109996546-B | P2X 3 And/or P2X 2/3 Compounds and methods | 阿沙纳生物科学公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116322626-A | Methods and compositions for classifying and/or treating postchin retraction in a subject in need thereof | 阿勒根公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116075295-A | Novel injectable oil-based pharmaceutical compositions | 南爱克萨股份公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-116056685-A | Methods, kits and compositions of novel agarose-based dermal fillers with enhanced rheological properties and safety performance | 先进美学科技公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115996686-A | Medical device comprising expandable muscle polymer | 巴德外周血管股份有限公司 | 2023-04-21 | — | — | CN | disclosed |
| US-20220127613-A1 | Functionally-Modified Oligonucleotides And Subunits Thereof | SAREPTA THERAPEUTICS INC (US) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127613-A1 | Functionally-Modified Oligonucleotides And Subunits Thereof | RTCB, NSUN3, NSUN2 | CYP2D6 4218/4885CYP1A2 4739/4885KMT2A 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.